Background illustration for clinical trials search

Paid Clinical Trials Conway

Discover 480 paid clinical trials in Conway, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

for
Schizophrenia, Bipolar I Disorder
Location: Little Rock AR, Atlanta GA, Decatur GA, Dothan AL,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 12 - 17

Code: NCT05648591

Recruiting

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

for
Influenza, Human+COVID-19
Location: Little Rock AR, Anniston AL, Austin TX, Stockbridge GA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65 - 70+

Code: NCT07464314

Phase 1, Recruiting

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

for
Chronic Spontaneous Urticaria
Location: Little Rock AR, Oklahoma City OK, Sugar Land TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07219615

Phase 2, Recruiting
New

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Bentonville AR, Richardson TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 18 - 65

Code: NCT07686263

Phase 3, Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

for
Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
Location: Little Rock AR, Saint Charles MO, Plano TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06229210

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

for
Irritability Associated With Autism Spectrum Disorder
Location: Little Rock AR, Shreveport LA, Oklahoma City OK,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06706674

Phase 3, Recruiting

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Richardson TX, Decatur GA, DeLand FL,
Sponsor: Leal Therapeutics, Inc

Sex: All

Age: 18 - 55

Code: NCT07734493

Phase 1, Recruiting

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

for
Bipolar I Disorder
Location: Little Rock AR, Bentonville AR, St Louis MO,
Sponsor: LB Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07494305

Phase 2, Recruiting

A Study of Brenipatide in Adult Participants With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, St Louis MO, DeSoto TX, Fort Worth TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 55

Code: NCT07410507

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Little Rock AR, Rogers AR, Flowood MS, St Louis MO,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951711

Phase 3, Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

for
Atopic Dermatitis
Location: North Little Rock AR, Tulsa OK, Birmingham AL, Macon GA,
Sponsor: LEO Pharma

Sex: All

Age: 0 - 11

Code: NCT06311682

Phase 3, Recruiting

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Location: North Little Rock AR, Westlake OH, Ocala FL, Fresno CA,
Sponsor: Altimmune, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07795164

Phase 3, Recruiting

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Bryant AR, Edmond OK, Dallas TX, Oklahoma City OK,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07573176

Phase 3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

for
Major Depressive Disorder
Location: Bryant AR, Bentonville AR, Saint Charles MO,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07076407

Phase 3, Recruiting

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

for
Depressive Disorder, Major
Location: Bryant AR, Edmond OK, Fort Worth TX, Wichita Falls TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT06559306

Phase 3, Recruiting

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

for
Acne Vulgaris
Location: Bryant AR, Rogers AR, Oklahoma City OK, Louisville KY,
Sponsor: Bausch Health Americas, Inc.

Sex: All

Age: 9 - 11

Code: NCT07524946

Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic,
Location: Bryant AR, Birmingham AL, Clarksville IN,
Sponsor: Apollo Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07599813

Phase 2, Recruiting

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for
Alopecia Areata
Location: Bryant AR, Frisco TX, Dallas TX, Smyrna TN,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 12 - 17

Code: NCT07133308

Phase 3, Recruiting

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

for
Tardive Dyskinesia
Location: Bryant AR, Houston TX, Marietta GA, Beachwood OH,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07365462

Phase 2, Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

for
Schizophrenia, Schizoaffective Disorder, Bipolar Disorder,
Location: Bryant AR, Austin TX, Omaha NE, Naperville IL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07105111

Recruiting